Kellsye P. Fabian

1.2k total citations
31 papers, 873 citations indexed

About

Kellsye P. Fabian is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kellsye P. Fabian has authored 31 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 21 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Kellsye P. Fabian's work include Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (9 papers). Kellsye P. Fabian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (9 papers). Kellsye P. Fabian collaborates with scholars based in United States, Spain and Netherlands. Kellsye P. Fabian's co-authors include James W. Hodge, Walter J. Storkus, Benjamin Wolfson, Michelle R. Padget, Jeffrey Schlom, Ronald J. Fecek, Patrick Soon‐Shiong, Kristen Solocinski, Shahrooz Rabizadeh and Clint Allen and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Kellsye P. Fabian

27 papers receiving 852 citations

Peers

Kellsye P. Fabian

IMMUN

ONCOL

PRM

James M. Leatherman United States

Lorenzo F. Fanchi Netherlands

Jan Martínek United States

Kerstin Wennhold Germany

Todd Bartkowiak United States

Tiffany C. Blair United States

Xuexiang Du United States

Heng Lin China

Stéphanie Corgnac France

Iva Truxová Czechia

James M. Leatherman United States

Kellsye P. Fabian

443 ×0.9

IMMUN

461 ×0.9

ONCOL

271 ×1.2

93 ×1.0

84 ×1.0

PRM

Citations per year, relative to Kellsye P. Fabian Kellsye P. Fabian (= 1×) peers James M. Leatherman

Countries citing papers authored by Kellsye P. Fabian

Since Specialization

Citations

This map shows the geographic impact of Kellsye P. Fabian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellsye P. Fabian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellsye P. Fabian more than expected).

Fields of papers citing papers by Kellsye P. Fabian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kellsye P. Fabian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellsye P. Fabian. The network helps show where Kellsye P. Fabian may publish in the future.

Co-authorship network of co-authors of Kellsye P. Fabian

This figure shows the co-authorship network connecting the top 25 collaborators of Kellsye P. Fabian. A scholar is included among the top collaborators of Kellsye P. Fabian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kellsye P. Fabian. Kellsye P. Fabian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fabian, Kellsye P., et al.. (2025). TIME for Endometrial Cancer: Advancements and Challenges in Therapeutic Targets for the Endometrial Cancer Tumor Immune Microenvironment. Cancer Immunology Research. 13(12). 1894–1910. 1 indexed citations

Fabian, Kellsye P., Ginette S. Santiago-Sánchez, Michelle R. Padget, et al.. (2024). Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models. Journal for ImmunoTherapy of Cancer. 12(10). e009712–e009712. 3 indexed citations

Santiago-Sánchez, Ginette S., Kellsye P. Fabian, & James W. Hodge. (2024). A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer Biology & Therapy. 25(1). 2308097–2308097. 12 indexed citations

Fabian, Kellsye P., Michelle R. Padget, Yvette Robbins, et al.. (2024). Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence. Frontiers in Oncology. 14. 1376622–1376622. 3 indexed citations

Franks, S. Elizabeth, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, et al.. (2023). Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer Immunology Immunotherapy. 72(8). 2783–2797. 4 indexed citations

Santiago-Sánchez, Ginette S., James W. Hodge, & Kellsye P. Fabian. (2022). Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation. Frontiers in Immunology. 13. 993624–993624. 13 indexed citations

Hoke, Austin T.K., Michelle R. Padget, Kellsye P. Fabian, et al.. (2021). Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells. Cancer Research Communications. 1(3). 127–139. 14 indexed citations

Fabian, Kellsye P., Benjamin Wolfson, & James W. Hodge. (2021). From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment. Frontiers in Oncology. 11. 728018–728018. 82 indexed citations

Fabian, Kellsye P. & James W. Hodge. (2021). The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy. Molecular Therapy — Oncolytics. 23. 266–276. 46 indexed citations

10.

Fabian, Kellsye P., Anthony S. Malamas, Michelle R. Padget, et al.. (2020). Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable. Cancer Immunology Research. 9(2). 239–252. 11 indexed citations

11.

Robbins, Yvette, Sarah Greene, Jay Friedman, et al.. (2020). Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife. 9. 43 indexed citations

12.

Fabian, Kellsye P., Michelle R. Padget, Renee N. Donahue, et al.. (2020). PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations. Journal for ImmunoTherapy of Cancer. 8(1). e000450–e000450. 126 indexed citations

13.

Ludwig, Sonja, Chang‐Sook Hong, Beatrice M. Razzo, et al.. (2019). Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma. Cancer Immunology Immunotherapy. 68(7). 1133–1141. 15 indexed citations

14.

Choi, Jae‐Yeon, Wissam Beaino, Ronald J. Fecek, et al.. (2018). Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma. Journal of Nuclear Medicine. 59(12). 1843–1849. 54 indexed citations

15.

Fabian, Kellsye P. & Walter J. Storkus. (2017). Immunotherapeutic Targeting of Tumor-Associated Blood Vessels. Advances in experimental medicine and biology. 1036. 191–211. 19 indexed citations

16.

Raϊch‐Regué, Dàlia, et al.. (2016). Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8⁺ effector T cell responses. OncoImmunology. 5(6). e1146841–e1146841. 22 indexed citations

17.

Fabian, Kellsye P. & Walter J. Storkus. (2016). Tumor blood vessel-associated antigens, DLK-1 and DLK-2, as targets for anti-cancer immunotherapy. The Journal of Immunology. 196(1_Supplement). 215.2–215.2.

18.

Chen, Lu, Kellsye P. Fabian, Jennifer L. Taylor, & Walter J. Storkus. (2013). Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity. Frontiers in Immunology. 4. 388–388. 30 indexed citations

19.

Taylor, Jennifer, Kellsye P. Fabian, Leonard J. Appleman, et al.. (2013). DLK1: A Novel Target for Immunotherapeutic Remodeling of the Tumor Blood Vasculature. Molecular Therapy. 21(10). 1958–1968. 28 indexed citations

20.

Cordonnier, C., Rodrigo Martino, Plı́nio Trabasso, et al.. (2004). Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients. Clinical Infectious Diseases. 38(9). 1229–1236. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact